- Home
- VAL vs LIVN Comparison
VAL vs LIVN Comparison
Compare VAL & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAL
- LIVN
- Stock Information
- Founded
- VAL 1975
- LIVN 1987
- Country
- VAL Bermuda
- LIVN United Kingdom
- Employees
- VAL N/A
- LIVN N/A
- Industry
- VAL Oil & Gas Production
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VAL Energy
- LIVN Health Care
- Exchange
- VAL Nasdaq
- LIVN Nasdaq
- Market Cap
- VAL 3.3B
- LIVN 2.8B
- IPO Year
- VAL N/A
- LIVN 1993
- Fundamental
- Price
- VAL $41.22
- LIVN $47.59
- Analyst Decision
- VAL Hold
- LIVN Buy
- Analyst Count
- VAL 7
- LIVN 7
- Target Price
- VAL $66.33
- LIVN $67.14
- AVG Volume (30 Days)
- VAL 1.6M
- LIVN 580.7K
- Earning Date
- VAL 10-30-2024
- LIVN 02-19-2025
- Dividend Yield
- VAL N/A
- LIVN N/A
- EPS Growth
- VAL 1769.90
- LIVN 759.09
- EPS
- VAL 14.61
- LIVN 0.43
- Revenue
- VAL $2,262,000,000.00
- LIVN $1,241,739,000.00
- Revenue This Year
- VAL $33.28
- LIVN $10.10
- Revenue Next Year
- VAL $1.35
- LIVN $5.43
- P/E Ratio
- VAL $2.82
- LIVN $111.11
- Revenue Growth
- VAL 30.45
- LIVN 11.04
- 52 Week Low
- VAL $40.41
- LIVN $43.15
- 52 Week High
- VAL $84.20
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- VAL 34.18
- LIVN 34.36
- Support Level
- VAL $41.66
- LIVN $45.95
- Resistance Level
- VAL $44.19
- LIVN $52.70
- Average True Range (ATR)
- VAL 2.03
- LIVN 1.47
- MACD
- VAL -0.22
- LIVN -0.38
- Stochastic Oscillator
- VAL 11.57
- LIVN 24.30
About VAL Valaris Limited
Valaris Ltd is the industry leader in offshore drilling services across all water depths and geographies. It is a high-quality rig fleet of ultra-deepwater drillships, versatile semisubmersibles and modern shallow-water jackups. It operates in Floaters, Jackups, ARO and Others. Its majority of the revenue comes from Floaters segment which includes drillships and semisubmersible rigs.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.